Nick is a partner in our life sciences and chemistry team in London.
His practice concentrates on pharmaceutical chemistry, regenerative medicine and immunotherapy. He has been significantly involved in patent applications relating to cloning (somatic cell nuclear transfer), stem cells, cancer immunotherapy / CAR-T cells, gene therapy, and monoclonal antibodies / novel antigen receptor proteins (IgNARs/VNARs). Additionally, he brings deep involvement in patent applications relating to controlled release / sustained release pharmaceutical formulations, genetic diagnosis and biomarkers, synthetic biology, and medical devices / diagnostic devices
Experience has provided Nick with an insight into intellectual property issues of research institutions, pharmaceutical and biotechnology companies.
His practice ranges from drafting original patent applications and devising filing strategies, to advising on intellectual property aspects of company mergers and acquisitions, including due diligence on intellectual property rights.
His European portfolio includes post-grant opposition proceedings at the EPO, contentious proceedings in other foreign jurisdictions, as well as obtaining Supplementary Protection Certificates for pharmaceuticals.
Nick’s memberships include: Chartered Institute of Patent Attorneys (CIPA), European Patent Office (EPI), International Association for the Protection of Intellectual Property (AIPPI), International Federation of Intellectual Property Attorneys (FICPI), The Intellectual Property Lawyers' Organisation (TIPLO), and The Biochemical Society
European Patent Attorney (1999)
Chartered UK Patent Attorney (1998)
European Design Attorney
IP Litigator - Patent
MSc in Management of Intellectual Property (1992) from Queen Mary College, University of London.
MSc thesis (1992) on "Molecular characterisation of the endocytic pathway using the fission yeast Schizosaccaromyces pombe" from the University of Birmingham
BSc honours degree in Biochemistry (1988) from the University of Birmingham
Chartered Institute of Patent Attorneys (CIPA)
European Patent Office (EPI)
International Association for the Protection of Intellectual Property (AIPPI)
International Federation of Intellectual Property Attorneys (FICPI)
The Intellectual Property Lawyers' Organisation (TIPLO)
The Biochemical Society
‘An introduction to international IP instruments relevant to electronics and software’, Intellectual Property in Electronics and Software, Part 1, Chapter 1, Globe Law & Business (2013)
‘Practical implications of the unitary patent system in Europe’, Pharmaceutical Patent Analyst 2(5), 585-590 (2013)
'An introduction to international IP instruments relevant to life sciences’, Intellectual Property in the Life Sciences, Part 1 Chapter 1, Global Law & Business, (2011)
‘Developments in the patentability of inventions relating to human embryonic stem cells’, Bio-Science Law Review, volume 12 (1), pages 3-7 (2011)
'Regenerative Medicine European Court to rule on stem cell patents’, Mednous, volume 5, (5), page 20, May 2011
N. Bassil, K.Cornish, N. Lee, T. Leonard, Protecting the protector: The intersection of IP and Immuno-Oncology, Kilburn & Strode, (2019)
N. Bassil, J. Duncombe, Patentability of plant products obtained by an essentially biological process, Kilburn & strode, (2019)